These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15047791)

  • 1. A syringe prescription program to prevent infectious disease and improve health of injection drug users.
    Rich JD; McKenzie M; Macalino GE; Taylor LE; Sanford-Colby S; Wolf F; McNamara S; Mehrotra M; Stein MD
    J Urban Health; 2004 Mar; 81(1):122-34. PubMed ID: 15047791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syringe prescription to prevent HIV infection in Rhode Island: a case study.
    Rich JD; Macalino GE; McKenzie M; Taylor LE; Burris S
    Am J Public Health; 2001 May; 91(5):699-700. PubMed ID: 11344871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.
    Zaller N; Jeronimo A; Bratberg J; Case P; Rich JD
    J Urban Health; 2010 Dec; 87(6):942-53. PubMed ID: 21116724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island.
    Zaller ND; Yokell MA; Nayak SM; Fu JJ; Bazazi AR; Rich JD
    J Urban Health; 2012 Aug; 89(4):659-70. PubMed ID: 22427232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
    Singer M; Baer HA; Scott G; Horowitz S; Weinstein B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing syringes to prevent HIV: a survey of infectious disease and addiction medicine physicians in Rhode Island.
    Rich JD; Whitlock TL; Towe CW; McKenzie M; Runarsdottir V; Aboagye-Kumi M; Burris S
    Subst Use Misuse; 2001 Apr; 36(5):535-50. PubMed ID: 11419486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.
    Cotten-Oldenburg NU; Carr P; DeBoer JM; Collison EK; Novotny G
    J Acquir Immune Defic Syndr; 2001 Jun; 27(2):183-92. PubMed ID: 11404541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island.
    Rich JD; Martin EG; Macalino GE; Paul RV; McNamara S; Taylor LE
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S58-61. PubMed ID: 12489617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law.
    Case P; Beckett GA; Jones TS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S94-101. PubMed ID: 9663631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reported experiences during syringe purchases in Providence, Rhode Island: implications for HIV prevention.
    Zaller ND; Yokell MA; Apeakorang N; Gaggin J; Case P
    J Health Care Poor Underserved; 2012 Aug; 23(3):1310-26. PubMed ID: 24212176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national physician survey on prescribing syringes as an HIV prevention measure.
    Macalino GE; Sachdev DD; Rich JD; Becker C; Tan LJ; Beletsky L; Burris S
    Subst Abuse Treat Prev Policy; 2009 Jun; 4():13. PubMed ID: 19505336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of one-time use of sterile syringes: a study of active injection drug users in seven United States metropolitan areas.
    Gleghorn AA; Wright-De Agüero L; Flynn C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S30-6. PubMed ID: 9663621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.
    Wright-De Agüero L; Weinstein B; Jones TS; Miles J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?
    Lurie P; Jones TS; Foley J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S45-51. PubMed ID: 9663623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018.
    Meyerson BE; Lawrence CA; Cope SD; Levin S; Thomas C; Eldridge LA; Coles HB; Vadiei N; Kennedy A
    Harm Reduct J; 2019 Sep; 16(1):57. PubMed ID: 31533730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringe source, use, and discard among injection-drug users in New Haven, Connecticut.
    Khoshnood K; Blankenship KM; Pollack HA; Roan CT; Altice FL
    AIDS Public Policy J; 2000; 15(3-4):88-94. PubMed ID: 12189714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health.
    Gostin LO
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S60-70. PubMed ID: 9663626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users.
    Rich JD; Dickinson BP; Liu KL; Case P; Jesdale B; Ingegneri RM; Nolan PA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S140-1. PubMed ID: 9663638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.